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Abstract
Background: It is well known that high fat diets (HFDs) induce obesity and an increase in proinflammatory
adipokines. Interleukin-6 (IL-6) is considered the major inflammatory mediator in obesity. Obesity is associated with
a vitamin deficiency, especially of vitamins E and D3. We examined the effects of vitamin D3 and vitamin E
supplementation on levels of IL-6 and IL-10 (as a marker of anti-inflammatory cytokines since, a balance between
pro- and anti-inflammatory cytokines is maintained) protein expression in adipose tissue of mice provided with an
HFD. Additionally, we measured the effects of vitamin E and vitamin D3 treatment on LPS-stimulated 3T3-L1
adipocytes IL-6 and IL-10 secretion.
Results: IL-6 protein levels and the IL-6/IL-10 ratio were decreased in epididymal white adipose tissue in groups
receiving vitamins E and D3 supplementation compared to the HFD group. A 24-hour treatment of vitamin D3 and
vitamin E significantly reduced the IL-6 levels in the adipocytes culture medium without affecting IL-10 levels.
Conclusions: Vitamin D3 and vitamin E supplementation in an HFD had an anti-inflammatory effect by decreasing
IL-6 production in epididymal adipose tissue in mice and in 3T3-L1 adipocytes stimulated with LPS. Our results
suggest that vitamin E and D3 supplementation can be used as an adjunctive therapy to reduce the
proinflammatory cytokines present in obese patients.
Introduction
The incidence of obesity has dramatically increased
during the past several decades [1]. In 2006, the World
Health Organization estimated that 1.6 billion adults
worldwide were overweight and 400 million adults were
obese [2]. Although morbidly obese people have a
greater food intake than non-obese people, they may
suffer from nutritional deficiencies.
High fat diets (HFDs) contribute to the accumulation
of adipose tissue, resulting in obesity and possibly insu-
lin resistance. Adipose tissue secretes soluble factors
called adipokines, which include pro-inflammatory cyto-
kines. It is known that long-term low systemic inflam-
mation that occurs in obese individuals contributes to
the development of metabolic syndrome [3]. Lira et al.
[4] reported that body fat correlates with cytokine levels,
and it was demonstrated that increased body fat was
associated with elevated cytokine levels in obese adoles-
cents. Tumor necrosis factor-a (TNF-a)a n di n t e r l e u -
kin-6 (IL-6), which are increased in obese subjects, may
downregulate adiponectin production. In contrast, adi-
ponectin reduces the production and activity of TNF-a
and IL-6. IL-6 is considered the major inflammatory
mediator in obesity. IL-6 has been implicated in the
release of triglycerides and free fatty acids, downregu-
lated lipoprotein lipase, insulin resistance, increased pro-
duction of reactive oxygen species and decreased nitric
oxide generation [5].
IL-10, which is an anti-inflammatory cytokine, may
antagonize the actions of IL-6 [5]. Recently, Hong et al.
(2010) demonstrated that IL-10 increases insulin
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any medium, provided the original work is properly cited.sensitivity, protects from obesity-associated macrophage
infiltration, prevents increases in proinflammatory cyto-
kines and may prevent the deleterious actions of pro-
inflammatory cytokines on insulin signaling and glucose
metabolism [6].
Obesity is associated with vitamin deficiencies. Low
concentrations of 25-hydroxyvitamin D3 have been
associated with an increased risk of diabetes and other
cardiovascular disease risk factors [7]. In patients with
metabolic syndrome, six weeks of alpha-tocopherol sup-
plementation reduced serum levels of TNF-a [8].
Antioxidant micronutrients have been proposed as
adjunctive therapy in patients with diabetes [9]. Indeed,
some minerals and vitamins are able to participate indir-
ectly in the reduction of oxidative stress in diabetic
patients by improving glycemic control and/or exerting
antioxidant activity. For example, Foss [10] speculated
that vitamin D deficiency is the cause of obesity, which
can be reversed by improving the levels of vitamin D.
On the contrary, Czernichow and colleagues [11]
demonstrated that the incidence of metabolic syndrome
was reduced in healthy individuals that were given an
anti-oxidant formula containing vitamin E, vitamin C,
beta-carotene, zinc and selenium.
Our hypothesis is that the well established proinflam-
matory effect of HFD ingestion on white adipose tissue
could be reduced by supplementation of vitamin D3 and
alpha-tocopherol (vitamin E). The aim of this study was
to examine the effects of vitamins D3 and E supplemen-
tation on the levels of IL-6 and IL-10 protein expression
in adipose tissue of mice provided with a HFD. Addi-
tionally, we evaluated the effects of vitamin E and vita-
min D3 on 3T3-L1 adipocytes stimulated with LPS in
terms of IL-6 and IL-10 secretion.
Materials and methods
The Experimental Research Committee of the São Paulo
Federal University approved all procedures for the care
of the animals used in this study (protocol n°2007/
0388). Thirty-day-old male Swiss mice were used in this
study and were kept under controlled conditions (12 h
light: 12 h dark cycle with lights on at 07:00; 22°C ± 1°C).
During the experimental period, the animals were group-
housed and provided water and a specific diet ad libitum.
The animals were treated for eight weeks as follows: 1)
HFD - Twelve animals were treated for eight weeks with
a hyperlipidic diet based on the AIN93 formulation with
20% of the fat from soya beans; 2) HFD Vitamin D3 -
Twelve animals were treated for four weeks with a hyper-
lipidic diet based on the AIN93 formulation with 20% of
the fat from soya beans and an additional four weeks
with the same diet supplemented with 1,25(OH)2 vitamin
D3 (0.05 mg/Kg of diet); and 3) HFD Vitamin E - Twelve
animals were treated for four weeks with a hyperlipidic
diet based on the AIN93 formulation with 20% of the fat
from soya beans and an additional four weeks with the
same diet supplemented with alpha-tocopherol (0.9 g/kg
of diet). The animals’ weight and food intake were evalu-
ated weekly.
Sample collection
After eight weeks the animals were euthanized by
decapitation without sedation. Retroperitoneal, mesen-
teric and epididymal fat pads were removed and
weighed to estimate the degree of obesity. Samples of
epididymal white adipose tissue were dissected, immedi-
ately frozen in liquid nitrogen and stored at -80°C.
Cell culture
3T3-L1 cells were obtained from the American Type
Culture Collection and cultured at a 37°C, 5% CO2 and
95% humidity. The cells were maintained in Dulbecco’s
Eagle modified medium (DMEM) supplemented with
25 mM glucose, 1.0 mM pyruvate, 4.02 mM L-alanyl-
glutamine and 10% fetal bovine serum (FBS) (Gibco).
The cells were differentiated 24 h after reaching con-
fluency for 4 days in a medium containing 0.25 μM dex-
amethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and
5 μg/mL insulin (Sigma). After the cells were differen-
tiated, the cells were cultured for 8 days in growth
medium containing 5 μg/ml of insulin.
Treatment
Eight days after the differentiation, the cells were pre-
treated with medium containing vitamin D3 (10
-7 M)
(1,25(OH)2 vitamin D3) and vitamin E (50 μM-a l p h a -
tocopherol) for 24 h. Cells were then treated with the
same medium along with LPS (75 ng/ml) for an addi-
tional 24 h before being harvested. No vitamins were
added to the control plates, but the medium was chan-
ged. The cultured medium was collected in tubes and
stored at -80°C.
Analysis of IL-6 and IL-10 levels
Adipose tissue samples were carefully rinsed in ice-cold
0.9% NaCl to remove any blood contaminants, snap fro-
zen in liquid nitrogen, and stored at -80°C. Frozen tissue
(0.1 g - 0.3 g) was homogenized in RIPA buffer (0.625%
Nonidet P-40, 0.625% sodium deoxycholate, 6.25 mM
sodium phosphate and 1 mM ethylenediamine tetraace-
tic acid at pH 7.4) containing 10 mg/ml protease inhibi-
tor cocktail (Sigma-Aldrich, St. Louis, Missouri).
Homogenates were centrifuged at 12,000 g for 10 min
at 4°C. The supernatant was saved and protein concen-
tration was determined by a Bradford assay (Bio-Rad,
Hercules, CA) using bovine serum albumin (BSA) as a
standard. Levels of IL-6 and IL-10 in adipose tissue and
medium culture were quantified by ELISA (DuoSet
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(DY506) and IL-10 (DY522) assay sensitivities were
found to be 5.0 pg/ml in the range of 31.2 - 2000 pg/ml.
T h ei n t r a -a n di n t e r - a s s a yv a r i a b i l i t yo ft h eI L - 6a n d
IL-10 kits was 2.7-5.2% and 4.9-9.5%, respectively. The
intra-assay variability of the IL-6 and IL-10 kits was
2.0-4.2%, and the inter-assay variability was 3.3-6.4%. All
samples were run as duplicates, and the mean values are
reported.
Statistical analysis
The results are expressed as a mean ± S.D. For statisti-
cal analysis, a one-way ANOVA was used to compare
the treatment effects (presence or absence of vitamin
D3 and vitamin E). Tukey’s test was applied for compar-




Vitamin D3 and vitamin E supplementation decreased
t h eb o d yw e i g h tg a i ni nm i c ep r o v i d e dw i t ha nH F D
(39%, p < 0.01 and 48%, p < 0.001, respectively). How-
ever, the adiposity index and energy intake were similar
among the studied groups (Table 1).
IL-6 protein content in epididymal adipose tissue
(WAT) was reduced (p < 0.05) by vitamin D3 (32%) and
vitamin E (61%) supplementation in mice treated with
HFD. Similar IL-10 WAT protein content was observed
among the groups, although the IL-6/IL-10 ratio was
reduced in groups supplemented with vitamins in rela-
tion to the HFD group, (vitamin D3: 50%, and vitamin
E: 57%, p < 0.01) (Table 1).
In vitro study
Twenty-four hours of LPS treatment caused an increase
in both IL-6 (approximately 14-fold) and IL-10 protein
concentration in 3T3-L1 adipocytes culture medium.
The IL-10 protein was not detectable in the control
medium.
Twenty-four hours of supplementation with vitamin
D3 and vitamin E in the adipocytes stimulated with LPS
significantly reduced the levels of IL-6 (88% and 60%,
respectively; p < 0.01) in the culture medium without
any effect on the IL-10 levels (Table 2). Vitamin D3 and
E reduced the IL-6/IL-10 ratio in adipocytes stimulated
with LPS (Table 2).
Discussion
Supplementation of vitamin D3 and vitamin E reduced
proinflammatory cytokine production by the WAT from
the HFD-fed mice. In the 3T3-L1 adipocytes, LPS sti-
mulated IL-6 and IL-10 production. Addition of vita-
mins D3 and E in the culture medium with LPS
significantly reduced IL-6 levels without altering IL-10
levels. These results suggest the importance of vitamins,
both in vivo and in vitro, in controlling the inflamma-
tory state in adipocytes.
Obesity occurs due to a complex combination of mul-
tiple environmental and genetic factors. Consumption of
highly energetic, fatty, and palatable foods is the most
important epidemiological predisposing factors to obe-
sity development [12,13]. Studies have shown that the
increase in the production of adipokines, such as PAI-1
[14], TNF-a [15] and IL-6, [16], and the reduction of
adiponectin [17] are critically involved in the pathogen-
esis of obesity.
HFD causes lipotoxic impairment of insulin action
and the regulatory mechanisms of body weight [18].
Mice fed with HFD supplemented with vitamin E and
vitamin D3 had a slight gain in body weight without
changes in the adiposity index and energy intake,
which suggested an increase in thermogenesis and
metabolic rate.
Several studies have shown an inverse association of
serum vitamin D3 levels with adiposity and body mass
index [19-22]. In addition, it has been demonstrated
that blockade of 3T3-L1 cell differentiation by vitamin
D3 involves C/EBPb suppression, PPARg upregulation,
and antagonist function of PPARg activity [23,24].
Table 1 Body weight again, epididymal adipose tissue weight, adiposity index and cytokines levels
High Fat High Fat plus Vit.D High Fat plus Vit.E
Body weight gain (g) 19.95 ± 4.47a 12.08 ± 4.59b 10.40 ± 2.46b
Energy intake (KJ/100 g b.w) 10272 ± 584a 10686 ± 495a 10686 ± 495a
Vitamin E intake (mg)
† 16.6 ± 2.4a 18.34 ± 1.17a 202.07 ± 17.88b
Vitamin D3 intake (mg)
† 0.049 ± 0.007a 0.064 ± 0.004b 0.051 ± 0.001a
Epididymal WAT weight (g) 1.01 ± 0.21a 0.72 ± 0.18a 0.88 ± 0.34a
Adiposity index (g) 1.86 ± 0.50a 1.29 ± 0.35a 1.33 ± 0.55a
IL-6 (pg/ug protein
-1) 115.88 ± 48.01a 66.29 ± 20.97b 44.94 ± 8.49b
IL-10 (pg/ug protein
-1) 28.46 ± 10.18a 43.42 ± 14.06a 32.30 ± 2.24a
IL-6/IL-10 3.23 ± 1.55a 1.63 ± 0.68b 1.39 ± 0.27b
Results are expressed as mean value ± SD.
†Vitamin consumption during the study. Different letters indicate statistically significant differences (p < 0.05).
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D receptor-null mice have a higher rate of fatty acid
beta-oxidation and an up regulation of uncoupling pro-
tein (UCP) 1, UCP2 and UCP3 expression in the WAT.
They also demonstrated that 1,25-dihydroxyvitamin D3
directly suppressed the expression of the UCPs in pri-
mary brown fat culture. They concluded that vitamin
D3 is involved in energy metabolism and adipocyte biol-
ogy in vivo in part through regulation of beta-oxidation
and UCP expression. The difference between this study
and the present study may be due to differences in the
protocols that were used.
Furthermore, Sun and Zemel [23] showed that calci-
triol increased production of reactive oxygen species
(ROS) by inhibiting UCP2 expression and stimulating
intracellular calcium influx, resulting in fatty acid synth-
esis and lipolysis inhibition. However, Zembel and Sun
[24] suggested that calcitriol exerts a dose-dependent
impact on adipocyte apoptosis, indicating that a low
physiological dose inhibits apoptosis and a pharmacolo-
gical dose stimulates apoptosis. More studies are neces-
sary to understand the effects of HFD with vitamin D3
and vitamin E supplementation on body weight gain
and thermogenesis.
The effect of vitamin E supplementation on body mass
index is not conclusive. Botella-Carretero and colleagues
[25] demonstrated an inverse correlation between vita-
min E and body mass index, whereas other studies have
reported no correlation [26,27].
Obesity and insulin resistance are associated with low
grade chronic systemic inflammation [28]. In models of
diet-induced obesity and genetic obesity, the adipose tissue
has increased expression of proinflammatory cytokines,
such as TNF-a, IL-1, and IL-6 [15,29]. Furthermore, fatty
acids increased IL-6 serum concentration and gene
expression in adipocytes [30], and a saturated fat-rich diet
increased IL-6 concentrations in human adipocytes [31].
The main result of our study is that treatment with vita-
min D3 and vitamin E reduces IL-6 levels in epididymal
adipose tissue (in vivo) and 3T3-L1 adipocytes (in vitro).
Low concentrations of vitamin D is the most common
vitamin deficiency associated with obesity and may be
closely linked to the increase in ROS which activates the
inflammatory pathway [7]. There is evidence that insulin
resistance results from the proinflammatory cytokines
actions released from the adipose tissue, such as TNF-a
and IL-6 [32].
Production of IL-6 increases with adiposity, and circu-
lating IL-6 concentrations are highly correlated with
percentage of body fat and insulin resistance [33]. Vita-
min E supplementation in patients with diabetes
decreases the levels of proinflammatory cytokines, such
as IL-1, TNF-a, IL-6, and reactive C protein, in serum
and stimulated monocytes [34,35]. In addition, high
intake of foods rich in vitamin E demonstrated an
inverse correlation with levels of C reactive protein and
IL-6 [36]. Elevated TNF-a concentrations cause stress
oxidation in monocytes which, conversely, increases low
density lipoprotein (LDL) oxidation [37]. Oxidative
modification of lipoproteins is an essential component
of the atherogenic process [34]. Manning et al. (2004)
showed that vitamin E supplementation decreased
plasma peroxide concentration in obese individuals [26].
In the present study, we demonstrated that a vitamin
D3- and vitamin E-supplemented diet decreases IL-6
levels in adipose tissue and in 3T3-L1 adipocytes. Taken
together, these results demonstrate that vitamin E and
vitamin D3 could have a direct effect on adipocytes.
In conclusion, vitamin D3 and vitamin E supplementa-
tion in HFD had an anti-inflammatory effect by decreas-
ing IL-6 production in epididymal adipose tissue in
mice and in 3T3-L1 adipocytes stimulated with LPS.
Potentially, our results suggest that vitamin E and D3
supplementation can be used as an adjunctive therapy
to reduce proinflammatory cytokines levels in obese
patients.
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